Recent news on Inversine

Deal reduces firm's net loss  -  May 9, 2007
Winston-Salem Journal (subscription),The company markets Inversine, a hypertension drug but does not earn substantial revenue from the product. The company reported revenue of $2.1 million for

QuitPak enters pilot study  -  Feb 13, 2007
In-PharmaTechnologist.com,Until 1997 Merck marketed mecamylamine as a hypertension treatment under the name Inversine, but never pursued the smoking cessation potential that was

Targacept to Report Second Quarter 2006 Financial Results on ...  Aug 2, 2006
Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive deficits ... -PR Newswire



Advance Patch Helps Smokers Quit  Feb 1, 2006
...patches and some received placebo patches. All participants were given the smoking cessation drug Inversine. A month later, half the ... - CBS News

Targacept tries again to make IPO work  Jan 17, 2006
...products. Targacept markets the drug Inversine, a treatment for hypertension, but it has no other source of product revenue. According ... - Winston-Salem Journal

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional